NCT05554237View on ClinicalTrials.gov

A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People.

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

October 7, 2022

Primary Completion Date

June 23, 2023

Study Completion Date

June 23, 2023

Conditions

Healthy

Interventions

DRUG

Placebo

Placebo

DRUG

PF-07612577

PF-07612577

DRUG

PF-06264006

PF-06264006

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05554237 - A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People. | Biotech Hunter | Biotech Hunter